Dunad Therapeutics is Drug Discovery in United Kingdom that focus on developer business. Founded in 2020. They cover business area such as developer, small-molecule degradation platform, protein degradation technology, selective degradation, direct target modification, tunable mono-valent small molecule, medical practitioner, disease-cause protein, direct modulation.
2020
( 4 years old in 2024 )
Developer
-
15th Floor 125 Old Broad Street
London EC2N 1AR
England, United Kingdom
Private
developersmall-molecule degradation platformprotein degradation technologyselective degradationdirect target modificationtunable mono-valent small moleculemedical practitionerdisease-cause proteindirect modulation
* We use standard office opening hours in near Dunad Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Dunad Therapeutics is Drug Discovery business from United Kingdom that founded in 2020 (4 years old in 2024), Dunad Therapeutics business is focusing on Developer.
Dunad Therapeutics headquarter office and corporate office address is located in 15th Floor 125 Old Broad Street London EC2N 1AR England, United Kingdom.
Dunad Therapeutics was founded in United Kingdom.
In 2024, Dunad Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Dunad Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
